Answers are grounded in this paper and cite their sources.
PrEP is feasible to implement in integrated reproductive health service delivery models to reach African AGYW. While PrEP demonstration projects indicate that women with behavioural risks and high rates of sexually transmitted diseases are initiating PrEP; effective strategies to support AGYW's adherence and persistence with PrEP are needed. Lessons learned from oral PrEP delivery, a novel first generation HIV prevention product, are relevant to longer-acting and less adherence-dependent strategies which are currently in clinical trials.
No takes yet. Share an insight, caveat, or question.
Celum et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: